ConductScience.org, home

Paper16640493

Nanoparticle-aptamer bioconjugates for cancer targeting.

Farokhzad OC and 2 others. Expert Opin Drug Deliv, 2006. Cited by 182 papers, by iCite.

Cite this record

ConductScience Library. Nanoparticle-aptamer bioconjugates for cancer targeting. Papers, record 16640493. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16640493

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nanoparticle-aptamer bioconjugates for cancer targeting.
PubMed
Journal
Expert Opin Drug Deliv
PubMed
Year
2006
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
182
iCite
Relative citation ratio, by iCite
4.75
iCite
Revised in PubMed
2019-11-09
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Farokhzad OCOmid C
2Karp JMJeffrey M
3Langer RRobert

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Aptamers, NucleotideMajor topic
Drug Delivery SystemsMajor topic
NanostructuresMajor topic
NeoplasmsMajor topic
Animals
Delayed-Action Preparations
Humans
SELEX Aptamer Technique
Surface Properties

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA 119349NCI NIH HHSUnited StatesU54CA119349PubMed and NIHNIH RePORTER
EB003647NIBIB NIH HHSUnited StatesK08EB003647PubMed and NIHNIH RePORTER

Download CSV of grants

Cited by75

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 182 citations.

PMIDTitleJournalYearIn PapersSource
41438702mRNA delivery systems 2.0: Engineering extrahepatic delivery for non-vaccine therapeutics.Mater Today Bio2025https://conductscience.org/library/papers/41438702PubMed
40873364Next-generation Mesoporous Silica Nanoparticles: Precision-engineered Platforms for Ovarian Cancer Therapy.Curr Drug Res Rev2026https://conductscience.org/library/papers/40873364PubMed
39891600Targeted nanoliposomes for precision rheumatoid arthritis therapy: a review on mechanisms and in vivo potential.Drug Deliv2025https://conductscience.org/library/papers/39891600PubMed
39757607Precision Oncology: Advances in Drug Delivery and Imaging.Recent Adv Drug Deliv Formul2025https://conductscience.org/library/papers/39757607PubMed
39434968Progressive cancer targeting by programmable aptamer-tethered nanostructures.MedComm (2020)2024https://conductscience.org/library/papers/39434968PubMed
38898204Development, Optimization, and in vitro Evaluation of Silybin-loaded PLGA Nanoparticles and Decoration with 5TR1 Aptamer for Targeted Delivery to Colorectal Cancer Cells.AAPS PharmSciTech2024https://conductscience.org/library/papers/38898204PubMed
38005286HA-Coated PLGA Nanoparticles Loaded with Apigenin for Colon Cancer with High Expression of CD44.Molecules2023https://conductscience.org/library/papers/38005286PubMed
36839929Pt(II)-PLGA Hybrid in a pH-Responsive Nanoparticle System Targeting Ovarian Cancer.Pharmaceutics2023https://conductscience.org/library/papers/36839929PubMed
36547533Metal Oxide Nanoparticles: Review of Synthesis, Characterization and Biological Effects.J Funct Biomater2022https://conductscience.org/library/papers/36547533PubMed
36376604TPGS Decorated Liposomes as Multifunctional Nano-Delivery Systems.Pharm Res2023https://conductscience.org/library/papers/36376604PubMed
36341415Targeted delivery of liposomal chemoimmunotherapy for cancer treatment.Front Immunol2022https://conductscience.org/library/papers/36341415PubMed
36145668"Targeting Design" of Nanoparticles in Tumor Therapy.Pharmaceutics2022https://conductscience.org/library/papers/36145668PubMed
36015307Functional Nanoparticles for Enhanced Cancer Therapy.Pharmaceutics2022https://conductscience.org/library/papers/36015307PubMed
36015276Selective Targeting and Eradication of Various Human Non-Small Cell Lung Cancer Cell Lines Using Self-Assembled Aptamer-Decorated Nanoparticles.Pharmaceutics2022https://conductscience.org/library/papers/36015276PubMed
35857350From Bench to Cell: A Roadmap for Assessing the Bioorthogonal "Click" Reactivity of Magnetic Nanoparticles for Cell Surface Engineering.Bioconjug Chem2022https://conductscience.org/library/papers/35857350PubMed
35642539Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?Chem Soc Rev2022https://conductscience.org/library/papers/35642539PubMed
34424426Zebrafish: A Promising Real-Time Model System for Nanotechnology-Mediated Neurospecific Drug Delivery.Nanoscale Res Lett2021https://conductscience.org/library/papers/34424426PubMed
34349972Precision photothermal therapy and photoacoustic imaging by in situ activatable thermoplasmonics.Chem Sci2021https://conductscience.org/library/papers/34349972PubMed
33266216Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy.Int J Mol Sci2020https://conductscience.org/library/papers/33266216PubMed
33228250Aptamer-Functionalized Natural Protein-Based Polymers as Innovative Biomaterials.Pharmaceutics2020https://conductscience.org/library/papers/33228250PubMed

See all 75 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16640493

GET https://conductscience.org/api/papers/v1/16640493/cited_by?page=2